Pancreatic functional impairment following acute necrotizing pancreatitis: long-term outcome of a non-surgically treated series

Dig Liver Dis. 2010 Feb;42(2):149-52. doi: 10.1016/j.dld.2009.08.007.

Abstract

Objectives: Patients who survive an episode of acute necrotizing pancreatitis may develop endocrine and exocrine pancreatic functional impairment; often these patients have undergone pancreatic surgery during the acute episode. Aim of this study is to report the results of a long-term follow-up of patients recovering from an episode of acute necrotizing pancreatitis which had not been treated surgically during the index hospital admission.

Design and subjects: Sixty-five consecutive patients enrolled between January 1990 and December 1993, prospectively followed through December 2006.

Results: Median follow-up period was 179.5 months (range 156-203). 40 patients (61.5%) who completed follow-up were analysed. Endocrine function: 2 patients (5%) were diabetic before the pancreatitis episode, and 6 (15.7%) developed overt diabetes; diabetes appeared within the 3rd year after acute pancreatitis in 2 patients, between the 3rd and 4th year in 2 patients, and between the 5th and 6th year in the last 2 patients. Exocrine function: 9 patients (22.5%) showed fecal elastase impairment; in all patients ultrasound was normal and fecal elastase returned above the normal limit during follow-up.

Conclusions: After an episode of acute necrotizing pancreatitis treated without surgery, the endocrine and exocrine function is not frequently impaired after long-term follow-up. Reduction in exocrine function is transient and complete recovery is achieved in all patients within a few years.

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus / etiology
  • Feces / enzymology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreas / physiology*
  • Pancreatic Elastase / analysis
  • Pancreatitis, Acute Necrotizing / complications
  • Pancreatitis, Acute Necrotizing / rehabilitation*
  • Pancreatitis, Acute Necrotizing / therapy
  • Prospective Studies
  • Recovery of Function*
  • Survivors

Substances

  • Pancreatic Elastase